Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Cost Comparison

Thymosin Alpha-1 pricing through legitimate compounding pharmacies ranges from $150-300 per month for standard dosing protocols, with costs varying based on pharmacy location and prescription volume[55]. Patients requiring higher doses for cancer treatment may

This comparison does not assign a generated winner or score.

  • Thymosin Alpha-1 pricing through legitimate compounding pharmacies ranges from $150-300 per month for standard dosing protocols, with costs varying based on pharmacy location and prescription volume[55]. Patients requiring higher doses for cancer treatment may face monthly costs of $400-600 through compounded sources[56]. Insurance coverage remains limited, as most plans classify Thymosin Alpha-1 as investigational for most indications[57]. Some specialty pharmacies offer patient assistance programs providing 20-30% discounts for cash-paying patients[58]. International sources may offer lower pricing, but quality and purity cannot be verified without proper analytical testing[59].
  • TB-500 pricing operates entirely in gray market channels, with significant variability in cost and quality[60]. Research chemical suppliers typically charge $200-500 per month for standard dosing protocols, with prices fluctuating based on supply chain factors[61]. The lack of regulatory oversight means purity and potency vary dramatically between suppliers, with some products containing less than 50% of labeled TB-500 content[62]. Higher-priced suppliers claiming pharmaceutical-grade quality may charge $600-800 monthly, though these claims cannot be independently verified[63]. The legal risks associated with TB-500 acquisition add additional costs and complications for potential users[64].
  • Monthly cost (standard dose)
  • $150-300
  • $200-500
  • High-dose protocols
  • $400-600
  • $600-800
  • Insurance coverage
  • Limited/none
  • None
  • Patient assistance
  • 20-30% discounts available
  • Quality assurance
  • Compounding pharmacy standards
  • Unregulated
  • Legal acquisition
  • Prescription required
  • Prohibited
More references

Related material

Comparison

Effectiveness Comparison

Clinical evidence for Thymosin Alpha-1 spans multiple Phase II and Phase III trials across various therapeutic indications[28]. The landmark Phase III trial for chronic hepatitis …

View details →
Comparison

Side-by-Side Comparison

Class — Thymosin Peptide FDA Status Research Use Primary Uses modulation of T-cell-related pathways, toll-like receptor activation, cytokine-associated signaling Tissue Repair, Re…

View details →
Comparison

Quick Comparison

Protein family: Thymosin Alpha-1 belongs to the alpha thymosin family (prothymosin alpha derivative); TB-500 belongs to the beta thymosin family (a Thymosin Beta-4 fragment). Sequ…

View details →